StockWatch
·

LINCOLN PHARMACEUTICALS LTD. Q3 FY26 Results

LINCOLNQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue166.321.8%13.5%
Total Income181.476.4%16.7%
Expenditure146.753.5%15.7%
PBT34.7220.5%21.1%
Net Profit28.6043.1%37.7%
OPM14.19%1.38pp3.44pp
NPM15.76%4.05pp2.41pp
EPS14.2843.1%37.7%
View full financials

Informational and educational content only. Not investment advice.